“Researchers at Tel Aviv University cooperated with three major Israeli medical centers to develop a new method for detecting protein aggregation in cells – a hallmark of Parkinson’s disease.
The technology can enable diagnosis up to 20 years before the first motor symptoms appear, facilitating treatment or even prevention of the severe disease which is currently incurable.
The novel approach is based on super-resolution microscopy combined with computational analysis, allowing for precise mapping of the aggregates’ molecules and structures. (…)
The researchers of TAU said: “Our technology will enable the detection of initial signs of Parkinson’s at the cellular level up to 20 years before the first motor symptoms appear. We hope that such early diagnosis will facilitate preventive treatment for this currently incurable disease.“
The study was piloted by researchers from the School of Neurobiology, Biochemistry & Biophysics at the Wise Faculty of Life Sciences, the Sagol School of Neuroscience, and the Faculty of Medical and Health Sciences at Tel Aviv University, led by Prof. Uri Ashery and PhD candidate Ofir Sade.
Other participants included: Prof. Anat Mirelman, Prof. Avner Thaler, Prof. Nir Giladi, Prof. Roy Alcalay, Prof. Sharon Hassin, Prof. Nirit Lev, Dr. Irit Gottfried, Dr. Dana Bar-On, Dr. Meir Kestenbaum, Dr. Saar Anis, Dr. Shimon Shahar, Daphna Fischel, Dr. Noa Barak-Broner, Shir Halevi, and Dr. Aviv Gour – all from Tel Aviv University, with some also affiliated with the Tel Aviv Sourasky (Ichilov), Sheba, or Meir Medical Centers. (…)”, according to Tel Aviv University.
(press release TAU. Selected/Edited/Shortened by VonNaftali)
pic by AI